Jessica Spark

Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

Cassandra Wannan, Barnaby Nelson, Jean Addington et al. · Schizophrenia Bulletin · 2024 · 63 citations · Full text

Psychopathology, Psychiatric Evaluation, Psychotropic Medication +19

2672 – Getting Better with age: Do Mindfulness & Psychological Well-Being Improve in Old Age?

Lydia Hohaus, Jessica Spark · European Psychiatry · 2013 · 46 citations

A Sequential Adaptive Intervention Strategy Targeting Remission and Functional Recovery in Young People at Ultrahigh Risk of Psychosis

Patrick D. McGorry, Cristina Mei, G. Paul Amminger et al. · JAMA Psychiatry · 2023 · 32 citations · Full text

Distinguishing schizophrenia spectrum from non-spectrum disorders among young patients with first episode psychosis and at high clinical risk: The role of basic self-disturbance and neurocognition

Jessica Spark, Łukasz Gawęda, Kelly Allott et al. · Schizophrenia Research · 2021 · 20 citations

Psychiatry, Risk Prediction, Psychotic Disorder +12

Cannabidiol for at risk for psychosis youth: A randomized controlled trial

G. Paul Amminger, Ashleigh Lin, Melissa Kerr et al. · Early Intervention in Psychiatry · 2021 · 14 citations